#TODAY Weight-Loss Pill Study Compares Effectiveness to Injectables
Weight-Loss Pill Study Compares Effectiveness to Injectables
Nearly 12% of Americans have used GLP-1s like Ozempic and Wegovy, which require a weekly injection. A new study from Novo Nordisk offers encouraging news in the race to develop a pill version of the medications. NBC’s medical contributor Dr. Natalie Azar joins TODAY to break down the results of the study, which includes the pill’s effectiveness, side effects and shares when it is expected to become available.
» Subscribe to TODAY: https://www.youtube.com/@TODAY
TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.
Connect with TODAY Online!
Visit TODAY’s Website: https://www.today.com/
Find TODAY on Facebook: https://ift.tt/BJn97vV
Follow TODAY on Twitter: https://twitter.com/TODAYshow
Follow TODAY on Instagram: https://ift.tt/Q0yOsKF
» Stream TODAY All Day: https://ift.tt/vUzj6Xs
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.
#weightloss #health #ozempic
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
コメントを送信